A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

NCT00644488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: BMS-641988 (AR#2)

Sponsor

Bristol-Myers Squibb